非酒精性脂肪性肝病相关肝癌——我们所知道的和不知道的
Nonalcoholic fatty liver disease-related hepatocellular carcinoma:what we know and unknown
邓朝华 1施军平2
作者信息
- 1. 杭州师范大学临床医学院,浙江 杭州 310015
- 2. 杭州师范大学临床医学院,浙江 杭州 310015;杭州师范大学附属医院感染和肝病科,浙江 杭州 311121
- 折叠
摘要
随着乙型肝炎病毒(HBV)疫苗接种率的提高和抗病毒药物的广泛使用,HBV和(或)丙型肝炎病毒(HCV)相关肝细胞癌(HCC)发病和病死人数已不再逐年增多.然而,全球肝癌相关死亡人数增加了 16％,主要原因是非酒精性脂肪性肝病(NAFLD)相关HCC患病率的快速增加.为此,当前需要高度重视NAFLD相关HCC的临床与基础研究.文章阐述了 NAFLD相关HCC的流行病学、监测、预防及治疗决策的当前现状以及所面临的挑战.
Abstract
With increased hepatitis B(HBV)vaccination rates and widespread use of antiviral drugs,the incidence and death of HBV or HCV-associated HCC are no longer increasing year by year.However,the number of liver cancer-related deaths increased by 16％globally,mainly due to the rapid increase in the prevalence of hepatocellular carcinoma(HCC)associated with non-alcoholic fatty liver disease(NAFLD).To this end,it is necessary to attach great importance to the clinical and basic research of NAFLD-HCC.This article describes the current status and challenges of NAFLD-related liver cancer epidemiology,surveillance,prevention,and treatment decisions.
关键词
非酒精性脂肪性肝病/肝细胞癌/临床特征/监测/防治策略Key words
nonalcoholic fatty liver disease/hepatocellular carcinoma/clinical features/surveillance/comprehensive management引用本文复制引用
出版年
2024
国家科技期刊平台
NSTL
万方数据